MiNK Therapeutics(INKT) - 2024 Q2 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Zack Armen - Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Jack Allen - Baird Mayank Mamtani - B. Riley Matthew Phipps - William Blair Operator Good morning and welcome to MiNK Therapeutics Secon ...